Impact of micronized progesterone on body weight, body mass index, and glucose metabolism: a systematic review

References

• Csapo AI, Pulkkinen M. Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence. Obstet Gynecol Surv 1978;33:69–81
   PubMedGoogle Scholar
• de Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16:316–37
   PubMed Web of Science ®Google Scholar
• Davis SR, Castelo-Branco C, Chedraui P, et al. Understanding weight gain at menopause. Climacteric 2012;15:419–29
   PubMed Web of Science ®Google Scholar
• Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 2013;34:309–38
   PubMed Web of Science ®Google Scholar
• Birkhauser MH, Panay N, Archer DF, et al. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 2008;11:108–23
   PubMed Web of Science ®Google Scholar
• Casanova G, Spritzer PM. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial. Lipids Health Dis 2012;11:133
   PubMed Web of Science ®Google Scholar
• Hassager C, Christiansen C. Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women. Metab Clin Exp 1989;38:662–5
   PubMed Web of Science ®Google Scholar
• Cicinelli E, de Ziegler D, Alfonso R, et al. Endometrial effects, bleeding control, and compliance with a new postmenopausal hormone therapy regimen based on transdermal estradiol gel and every-other-day vaginal progesterone in capsules: a 3-year pilot study. Fertil Steril 2005;83:1859–63
   PubMed Web of Science ®Google Scholar
• Di Carlo C, Tommaselli GA, Gargano V, et al. Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns. Climacteric 2010;13:442–6
   PubMed Web of Science ®Google Scholar
• Espeland MA, Stefanick ML, Kritz-Silverstein D, et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab 1997;82:1549–56
   PubMed Web of Science ®Google Scholar
• Cicinelli E, de Ziegler D, Galantino P, et al. Twice-weekly transdermal estradiol and vaginal progesterone as continuous combined hormone replacement therapy in postmenopausal women: a 1-year prospective study. Am J Obstet Gynecol 2002;187:556–60
   PubMed Web of Science ®Google Scholar
• Di Carlo C, Sammartino A, Di Spiezio Sardo A, et al. Bleeding patterns during continuous estradiol with different sequential progestogens therapy. Menopause 2005;12:520–5
   PubMed Web of Science ®Google Scholar
• Casanova G, dos Reis AM, Spritzer PM. Low-dose oral or non-oral hormone therapy: effects on C-reactive protein and atrial natriuretic peptide in menopause. Climacteric 2015;18:86–93
   PubMed Web of Science ®Google Scholar
• Mosnier-Pudar H, Faguer B, Guyenne TT, Tchobroutsky G. [Effects of deprivation and replacement by percutaneous 17 beta estradiol and oral progesterone on blood pressure and metabolic parameters in menopause patients with non-insulin-dependent diabetes]. Arch Mal Coeur Vaiss 1991;84:1111–5
   PubMedGoogle Scholar
• Stephenson K, Neuenschwander PF, Kurdowska AK. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women. Int J Pharm Compd 2013;17:74–85
   PubMedGoogle Scholar
• Espeland MA, Hogan PE, Fineberg SE, et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions. Diabetes Care 1998;21:1589–95
   PubMed Web of Science ®Google Scholar
• Bolaji II, Grimes H, Mortimer G, et al. Low-dose progesterone therapy in oestrogenised postmenopausal women: effects on plasma lipids, lipoproteins and liver function parameters. Eur J Obstet Gynecol Reprod Biol 1993;48:61–8
   PubMed Web of Science ®Google Scholar
• Spritzer PM, Vitola D, Vilodre LC, et al. One year follow-up of hormone replacement therapy with percutaneous estradiol and low-dose vaginal natural progesterone in women with mild to moderate hypertension. Exp Clin Endocrinol Diabetes 2003;111:267–73
   PubMed Web of Science ®Google Scholar
• Darj E, Nilsson S, Axelsson O, Hellberg D. Clinical and endometrial effects of oestradiol and progesterone in post-menopausal women. Maturitas 1991;13:109–15
   PubMed Web of Science ®Google Scholar
• Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1995;273:199–208
   PubMed Web of Science ®Google Scholar
• Araujo DA, Farias ML, Andrade AT. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Climacteric 2002;5:286–92
   PubMed Web of Science ®Google Scholar
• Casanova G, Radavelli S, Lhullier F, Spritzer PM. Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause. Fertil Steril 2009;92:605–12
   PubMed Web of Science ®Google Scholar
• Bolaji II, Mortimer G, Grimes H, et al. Clinical evaluation of near-continuous oral micronized progesterone therapy in estrogenized postmenopausal women. Gynecol Endocrinol 1996;10:41–7
   PubMed Web of Science ®Google Scholar
• Kapoor E, Collazo-Clavell ML, Faubion SS. Weight gain in women at midlife: a concise review of the pathophysiology and strategies for management. Mayo Clin Proc 2017;92:1552–8
   PubMed Web of Science ®Google Scholar
• Gonzalez-Garcia I, Tena-Sempere M, Lopez M. Estradiol regulation of brown adipose tissue thermogenesis. Adv Exp Med Biol 2017;1043:315–35
   PubMedGoogle Scholar
• Regidor P-A. Progesterone in peri- and postmenopause: a review. Geburtshilfe Frauenheilkd 2014;74:995–1002
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Volpe A, Paoletti AM, Melis GB. Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. Fertil Steril 1997;68:421–5
   PubMed Web of Science ®Google Scholar
• Caufriez A, Leproult R, L'Hermite-Baleriaux M, Kerkhofs M, Copinschi G. Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women. J Clin Endocrinol Metab 2011;96:E614–23
   PubMed Web of Science ®Google Scholar
• Copinschi G, Caufriez A. Sleep and hormonal changes in aging. Endocrinol Metab Clin North Am 2013;42:371–89
   PubMed Web of Science ®Google Scholar
• Burkman RT, Fisher AC, LaGuardia KD. Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use. J Reprod Med 2007;52:1030–4
   PubMed Web of Science ®Google Scholar
• Oelkers W. The renin-aldosterone system and drospirenone. Gynecol Endocrinol 2002;16:83–7
   PubMed Web of Science ®Google Scholar
• Goodman MP. Are all estrogens created equal? A review of oral vs. transdermal therapy. J Womens Health (Larchmt) 2012;21:161–9
   PubMed Web of Science ®Google Scholar
• The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The hormone therapy position statement of The North American Menopause Society. Menopause 2017;24:728–53
   PubMed Web of Science ®Google Scholar
• Sarri G, Davies M, Lumsden MA, Guideline Development Group. Diagnosis and management of menopause: summary of NICE guidance. BMJ 2015;351:5746
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A, IMS Writing Group. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar
• Armeni E, Lambrinoudaki I, Ceausu I, et al. Maintaining postreproductive health: a care pathway from the European Menopause and Andropause Society (EMAS). Maturitas 2016;89:63–72
   PubMed Web of Science ®Google Scholar
• Washburn BS, Krantz JS, Avery EH, Freedland RA. Effects of estrogen on gluconeogenesis and related parameters in male rainbow trout. Am J Physiol 1993;264:R720–5
   PubMedGoogle Scholar
• Ruan X, Mueck AO. Systemic progesterone therapy-oral, vaginal, injections and even transdermal? Maturitas 2014;79:248–55
   PubMed Web of Science ®Google Scholar
• Stanczyk FZ, Hapgood JP, Winer S, Mishell DR. Jr., Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev 2013;34:171–208
   PubMed Web of Science ®Google Scholar
• Kuhl H. Pharmacology of Progestogens. J Reproduktionsmed Endokrinol 2011;8:157–77
   Google Scholar
• Prior JC. Progesterone for treatment of symptomatic menopausal women. Climacteric 2018;21:358–65
   PubMed Web of Science ®Google Scholar
• Schumacher M, Mattern C, Ghoumari A, et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog Neurobiol 2014;113:6–39
   PubMed Web of Science ®Google Scholar
• Stute P, Neulen J, Wildt L. The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric 2018;21:111–22
   PubMed Web of Science ®Google Scholar
• Canonico M, Carcaillon L, Plu-Bureau G, et al. Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen. Stroke 2016;47:1734–41
   PubMed Web of Science ®Google Scholar
• Canonico M, Fournier A, Carcaillon L, et al. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study. Arterioscler Thromb Vasc Biol 2010;30:340–5
   PubMed Web of Science ®Google Scholar